Penetration Testing Isn't About Finding Vulnerabilities—It's About Reducing Business Risk
Penetration Testing Isn’t About Finding Vulnerabilities—It’s About Reducing Business Risk The most valuable penetration ...
Customer Story
A mid-sized pharmaceutical company with around $150m in revenue and 300 employees is rapidly expanding to new regions across the United States and abroad.
Mid-sized pharmaceutical company
$150M revenue
300 employees
Pharmaceutical
vCISO
The Challenge
The CIO owned all IT, Infrastructure and Security for the organization. As the company expanded, the security, compliance, and privacy requirements became critical for business operations.
The CIO required help around mitigating risk and protecting the company from threats and fines from HIPAA or GDPR/CCPA violations. The company faced challenges with limited security technology, inadequate processes, and insufficient documentation.
The lack of security expertise on staff hindered the organization from continued growth.
Our Solution
RKON provided a vCISO with pharmaceutical expertise, enabling rapid impact and value creation.
RKON provided on- demand expert security leadership to advance a cost-effective security program and establish clear communication with management, board of directors, investors and the government/regulators. RKON crafted a multi-year strategy to enhance security operations and technical capabilities while conducting security control assessments aligned with industry standards.
The IAM program was able to define its delivery objectives and measure with a management level balanced scorecard. New capabilities for privileged access management, secrets management, and vendor privilege management were expanded.The use and creation of roles increased, while entitlement-based provisioning decreased, leading to streamlined access requests and reviews with reduced processing times.The overall refined solution provided a solid foundation for more advanced capabilities including passwordless authentication, advanced identity proofing, and fine grained access controls to support zero trust initiatives.
COMPREHENSIVE SECURITY PROGRAM
SECURITY DUE DILIGENCE PROCESS
Penetration Testing Isn’t About Finding Vulnerabilities—It’s About Reducing Business Risk The most valuable penetration ...
Cyber Risk Is Continuously Evolving. Your Security Validation Strategy Should Keep Pace. Many organizations view penetra...
Why Validating Your Defenses Is Just as Important as Investing in Them Organizations continue to invest heavily in cyber...
The System Security Plan is dead. FedRAMP’s Consolidated Rules for 2026 (CR26), published June 24, retired the document ...